DexCom (DXCM) closed at $235.45 within the newest buying and selling session, marking a +0.65% transfer from the prior day. The inventory outpaced the S&P 500’s each day lack of 1.57%. Elsewhere, the Dow misplaced 1.57%, whereas the tech-heavy Nasdaq misplaced 1.89%.
Coming into right now, shares of the medical machine firm had gained 8.65% prior to now month. In that very same time, the Medical sector misplaced 1.74%, whereas the S&P 500 gained 2.35%.
Traders might be hoping for power from DXCM because it approaches its subsequent earnings launch, which is anticipated to be February 13, 2020. The corporate is anticipated to report EPS of $0.72, up 33.33% from the prior-year quarter. In the meantime, our newest consensus estimate is looking for income of $457 million, up 35.21% from the prior-year quarter.
Traders must also word any latest modifications to analyst estimates for DXCM. These latest revisions are likely to mirror the evolving nature of short-term enterprise traits. As such, constructive estimate revisions mirror analyst optimism in regards to the firm’s enterprise and profitability.
…